We show that DOX elicits dose-dependent induction of RAD51 expression at both mRNA and protein levels, and that treated MM cells arrest in the S and G2 cell-cycle phases wherein HR predominantly occurs. The gene discussed is RAD51; the disease is Miyoshi myopathy.